GEN ILAC VE SAGLIK URUNLERI SANAYI VE TIC A.S.

GEN ILAC VE SAGLIK URUNLERI SANAYI VE TIC A.S. is a manufacturer.

Company Introduction:

GEN ILAC VE SAGLIK URUNLERI SANAYI VE TIC A.S. is a prominent Turkish pharmaceutical company. Established in 1998, the company is primarily a manufacturer, operating its own modern production facilities dedicated to the research, development, and manufacturing of pharmaceutical and health products.

GEN ILAC specializes in providing innovative solutions for patients with specific needs, with a strong focus on rare diseases, oncology, neurology, and other specialized therapeutic areas. Beyond manufacturing, the company is also actively involved in the marketing, sales, and distribution of its products, both domestically within Turkey and internationally. Committed to improving the quality of life for patients, GEN ILAC emphasizes high quality standards and ethical practices throughout its operations, from production to market delivery.

GEN ILAC VE SAGLIK URUNLERI SANAYI VE TIC A.S. (GENILAC) manufactures and markets a comprehensive portfolio of pharmaceutical products. Their product range covers multiple therapeutic areas, including oncology for various cancer treatments, hematology for blood disorders, and drugs specifically developed for rare diseases. They also provide immunology products, often including biosimilars for autoimmune conditions, and neurology medications for central nervous system disorders. Furthermore, their offerings extend to anti-infective agents, cardiovascular drugs for heart and circulatory health, and treatments for metabolic diseases such as diabetes. Products for gastroenterology addressing digestive issues and dermatology for skin conditions are also part of their extensive portfolio. This includes both generic pharmaceuticals and advanced biosimilar products.